Join UBC at World Drug Safety Congress Europe 2023

Tuesday, September 12, 2023

UBC is proud to be a gold sponsor of one of Europe’s premier drug safety and risk management events. The World Drug Safety Congress Europe is hosted by Terrapinn in Amsterdam on October 4 and 5. This meeting will bridge regulatory bodies, industry professionals, and patient representatives. UBC’s safety and risk management team is looking forward to discussing the latest developments in mitigating risk and ensuring patient safety.

Our Presentation

Be sure to mark your agenda on day 1 for UBC’s presentation. At 3:35 PM on October 4, they will discuss Cutting Edge Insights into Vaccine Safety in Preterm Infants: A 2023 Update. This will be presented by Associate Director of Pharmacovigilance Antoinette Defaux and Safety Scientist Camille Lenoir.

Meet with UBC

To talk further with our team about this presentation or our capabilities, you can find us at booth #109 in the exhibit hall. If you would like to start the conversation early or set up formal time with us, please fill out the form below and we will reach out to you shortly.

UBC’s approach to Safety and Risk Management stems from our epidemiological, multidisciplinary foundation. Our commitment to Patients First has driven us to balance high-tech solutions with a personalized, experienced touch in our program design and execution. Our consultation, design, and implementation aim to reduce stakeholder burden, minimize barriers to access, and ensure product safety and value.